These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 4623947)

  • 1. In vivo activity of in vitro immunized lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes.
    Rouse BT; Wagner H; Harris AW
    J Immunol; 1972 May; 108(5):1353-61. PubMed ID: 4623947
    [No Abstract]   [Full Text] [Related]  

  • 2. Allograft immunity in the mouse. 1. Quantitation and specificity of cytotoxic effector cells after in vitro sensitization.
    MacDonald HR; Phillips RA; Miller RG
    J Immunol; 1973 Aug; 111(2):565-74. PubMed ID: 4123983
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro induction of tumor specific immunity: requirements for T lymphocytes and tumor growth inhibition in vivo.
    Röllinghoff M; Wagner H
    Eur J Immunol; 1973 Aug; 3(8):471-6. PubMed ID: 4543174
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies of allograft immunity in mice. I. Induction, development and in vitro assay of cellular immunity.
    Brunner KT; Mauel J; Rudolf H; Chapuis B
    Immunology; 1970 Apr; 18(4):501-15. PubMed ID: 4986975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytotoxic lymphocytes and anti-tumor immunity].
    Cerottini JC; Brunner KT
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):659-68. PubMed ID: 4403239
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cellular mechanisms of transplantation and tumor immunity].
    Brunner KT
    Schweiz Med Wochenschr; 1972 Aug; 102(33):1144-7. PubMed ID: 4403396
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction of thymus lymphocytes with histoincompatible cells. 3. Immunological characteristics of recirculating lymphocytes derived from activated thymus cells.
    Sprent J; Miller JF
    Cell Immunol; 1972 Feb; 3(2):213-30. PubMed ID: 4400932
    [No Abstract]   [Full Text] [Related]  

  • 8. The in vivo activity of in vitro immunized mouse thymocytes. II. Rejection of skin allografts and graft-vs-host activity.
    Rouse BT; Wagner H
    J Immunol; 1972 Dec; 109(6):1282-9. PubMed ID: 4404454
    [No Abstract]   [Full Text] [Related]  

  • 9. Thymus-derived cells as killer cells in cell-mediated immunity.
    Miller JF; Brunner KT; Sprent J; Russell PJ; Mitchell GF
    Transplant Proc; 1971 Mar; 3(1):915-7. PubMed ID: 4106348
    [No Abstract]   [Full Text] [Related]  

  • 10. The in vivo activity of in vitro immunized mouse thymocytes. 3. Fate of in vitro immunized thymocytes.
    Rouse BT; Wagner H
    Transplantation; 1973 Sep; 16(3):161-70. PubMed ID: 4199580
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell-mediated immune response in vitro. II. The role of thymus and thymus-derived lymphocytes.
    Wagner H; Harris AW; Feldmann M
    Cell Immunol; 1972 May; 4(1):39-50. PubMed ID: 4401545
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of tolerance with antilymphocytic serum.
    Lance EM; Medawar PB
    Transplant Proc; 1969 Mar; 1(1):429-32. PubMed ID: 4944254
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice.
    Takei F; Levy JG; Kilburn DG
    J Immunol; 1976 Feb; 116(2):288-93. PubMed ID: 814160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymus-derived lymphocytes as effectors of cell-mediated immunity to syngeneic and allogeneic transplants in the rat.
    Tucker DF; Dennert G; Lennox ES
    J Immunol; 1974 Oct; 113(4):1302-12. PubMed ID: 4547337
    [No Abstract]   [Full Text] [Related]  

  • 15. The relative distribution of cytotoxic lymphocytes and of alloantibody-forming cells in albumin density gradients.
    Pelet J; Brunner KT; Nordin AA; Cerottini JC
    Eur J Immunol; 1971 Aug; 1(4):238-42. PubMed ID: 5003410
    [No Abstract]   [Full Text] [Related]  

  • 16. Thymocytes from mice immunized against an allograft render bone-marrow cells specifically cytotoxic.
    Grant CK; Currie GA; Alexander P
    J Exp Med; 1972 Jan; 135(1):150-64. PubMed ID: 5009704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The specificity of concomitant tumor immunity at large tumor volumes.
    Deckers PJ; Pardridge DH; Wang BS; Mannick JA
    Cancer Res; 1976 Oct; 36(10):3690-4. PubMed ID: 953994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of macrophages in tumour immunity. 3. Co-operation between macrophages and lymphoid factors in an in vitro allograft situation.
    Evans R; Grant CK
    Immunology; 1972 Nov; 23(5):677-87. PubMed ID: 4673868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated immune responses in vitro. V. A comparative study of in vitro immunogenicity of splenic lymphocytes, neoplastic lymphoid cells and fibroblats.
    Wagner H; Wyss C
    Eur J Immunol; 1973 Sep; 3(9):549-55. PubMed ID: 4271926
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of cyclophosphamide on the rejection of allogenic rat kidney transplants. An in vitro study of cell-bound and antibody-mediated immunity.
    Husberg BS
    Clin Exp Immunol; 1972 Apr; 10(4):697-711. PubMed ID: 4556105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.